Following on from our participation in December’s investor-style forum for non-profit foundations, Partnering for Cures, we are delighted to announce that the Children’s Tumor Foundation has been invited by the Biotechnology Industry Organization (BIO) to present our neurofibromatosis research programs and drug pipeline at the 12th Annual BIO CEO and Investors Conference (www.ceo.bio.org) in New York on February 8-9. This meeting is attended by investors seeking investment opportunities with biotech companies. In the past couple of years a small number of research foundations have also been invited to speak. For the Children’s Tumor Foundation this provides us an opportunity to showcase our programs in preclinical drug screening and clinical trials, and potentially identify industry drug collaborations and new sources of funding. More news to follow!
Foundation to Present Neurofibromatosis Drug Pipeline at BIO Investor Event
